EUVIMEDEUVIMED entdecken
Crossref

Design of a Tetravalent RGD Peptide Capable of Simultaneous Binding with Multiple Integrin αvβ3 for Targeted Radionuclide Therapy

Yuki Mizuno iD, Thanakrit Suebboonprathueng, Satoru Onoe, Hiromichi Akizawa iD, Ken-Ichi Nishijima, Kazuhiro Takahashi, Yuji Kuge

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.4c03007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Yuki Mizuno und 6 weiteren Autor:innen. Beteiligte Einrichtung: Central Institute of Isotope Science, Hokkaido University, Sapporo 060-0815, Japan. Hauptthemen laut MEDLINE: Integrin alphaVbeta3, Oligopeptides, Iodine Radioisotopes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For targeted radionuclide therapy, radioligands that exhibit high and persistent tumor uptake are indispensable. We previously synthesized a 99mTc-labeled hexavalent RGD peptide (99mTc-(RGD)6) as a tumor imaging agent targeting integrin αvβ3. 99mTc-(RGD)6 showed high in vivo tumor uptake with long retention due to simultaneous binding to multiple integrin αvβ3 receptors. The purpose of this study was to apply this finding to the design of a multivalent RGD peptide labeled with 211At, a promising α-emitting radionuclide for radionuclide therapy. As a candidate compound, a tetravalent RGD peptide (H2N-(RGD)4) was synthesized and radiolabeled with 125I, a homologous element of At, for basic studies. As expected, 125I-(RGD)4 retained the capability of simultaneous binding and showed comparable in vivo tumor uptake to 99mTc-(RGD)6. Finally, 211At-(RGD)4 was synthesized with >95% radiochemical purity and exhibited an almost identical biodistribution pattern to 125I-(RGD)4. These results indicate that 211At-(RGD)4 might be a potential radioligand for integrin αvβ3-targeted radionuclide therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Integrin alphaVbeta3OligopeptidesIodine RadioisotopesAnimalsMiceHumansTissue DistributionRadiopharmaceuticalsCell Line, TumorDrug DesignMice, NudeMice, Inbred BALB CFemale

Substanzen

Integrin alphaVbeta3Oligopeptidesarginyl-glycyl-aspartic acidIodine RadioisotopesRadiopharmaceuticalsIodine-125

Autor:innen und Institutionen

  • Central Institute of Isotope Science, Hokkaido University, Sapporo 060-0815, Japan.
  • Global Center for Biomedical Science and Engineering, Hokkaido University, Sapporo 060-8638, Japan.
  • Graduate School of Biomedical Science and Engineering, Hokkaido University, Sapporo 060-8638, Japan.
  • Laboratory of Physical Chemistry, Showa Pharmaceutical University, Machida 194-8543, Japan.
  • Advanced Clinical Research Center, Fukushima Medical University, Fukushima 960-1295, Japan.

ORCID-Profile: Yuki Mizuno, Hiromichi Akizawa

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Mizuno, Y., Suebboonprathueng, T., Onoe, S., Akizawa, H., Nishijima, K. I., Takahashi, K., & Kuge, Y. (2025). Design of a Tetravalent RGD Peptide Capable of Simultaneous Binding with Multiple Integrin αvβ3 for Targeted Radionuclide Therapy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c03007

Vancouver

Mizuno Y, Suebboonprathueng T, Onoe S, Akizawa H, Nishijima KI, Takahashi K, et al. Design of a Tetravalent RGD Peptide Capable of Simultaneous Binding with Multiple Integrin αvβ3 for Targeted Radionuclide Therapy. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c03007

BibTeX
@article{Mizuno2025,
  author = {Mizuno, Yuki and Suebboonprathueng, Thanakrit and Onoe, Satoru and Akizawa, Hiromichi and Nishijima, Ken-Ichi and Takahashi, Kazuhiro and Kuge, Yuji},
  title = {Design of a Tetravalent RGD Peptide Capable of Simultaneous Binding with Multiple Integrin αvβ3 for Targeted Radionuclide Therapy},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.4c03007}
}
Kostenlos starten →